Biocon Biologics receives EU GMP certificate for new facility in Bengaluru
|
|
05-Jul-22
20:03
Hrs IST
|
|
Biocon announced that its subsidiary, Biocon Biologics has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022. Powered by Capital Market - Live News |
|
|